A clinical trial to evaluate the safety and immunogenicity of the LEISH-F1+MPL-SE vaccine when used in combination with sodium stibogluconate for the treatment of mucosal leishmaniasis-Reference-Cited by-同舟云学术

A clinical trial to evaluate the safety and immunogenicity of the LEISH-F1+MPL-SE vaccine when used in combination with sodium stibogluconate for the treatment of mucosal leishmaniasis

Published:2010-10 Issue:46 Volume:28 Page:7427-7435
ISSN:0264-410X
Container-title:Vaccine
language:en
Short-container-title:Vaccine

Author:

Llanos-Cuentas Alejandro,Calderón Wessmark,Cruz María,Ashman Jill A.,Alves Fabiana P.,Coler Rhea N.,Bogatzki Lisa Y.,Bertholet Sylvie,Laughlin Elsa M.,Kahn Stuart J.,Beckmann Anna Marie,Cowgill Karen D.,Reed Steven G.,Piazza Franco M.

Publisher

Elsevier BV

Subject

Infectious Diseases,Public Health, Environmental and Occupational Health,General Veterinary,General Immunology and Microbiology,Molecular Medicine

Reference13 articles.

1. Leishmaniasis;Magill,2000

2. Safety and immunogenicity of a defined vaccine for the prevention of cutaneous leishmaniasis;Velez;Vaccine,2010

3. Immunization with a polyprotein vaccine consisting of the T-Cell antigens thiol-specific antioxidant, Leishmania major stress-inducible protein 1, and Leishmania elongation initiation factor protects against leishmaniasis;Coler;Infect Immun,2002

4. Efficacy of sodium stibogluconate alone and in combination with allopurinol for treatment of mucocutaneous leishmaniasis;Llanos-Cuentas;Clin Infect Dis,1997

5. Monitoring and reporting adverse events: Appendix VII www resource links;ICSSC,2003

Cited by 60 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. PLGA nanoparticle-delivered Leishmania antigen and TLR agonists as a therapeutic vaccine against cutaneous leishmaniasis in BALB/c mice;International Immunopharmacology;2024-09

2. Vaccine Development for Human Leishmaniasis;Vaccines for Neglected Pathogens: Strategies, Achievements and Challenges;2023

3. Feasibility of Therapeutic Vaccine for the Management and Control of VL;Challenges and Solutions Against Visceral Leishmaniasis;2023

4. Parasitic Disease Vaccines;Plotkin's Vaccines;2023

5. Evolution of Adjuvants Across the Centuries;Plotkin's Vaccines;2023